How to pay for Ozempic, Wegovy and Zepbound in 2026

Updated October 23, 2026 · Sources listed below

The short answer

Most people pay for a GLP-1 through commercial insurance, Medicare, Medicaid or the makers' self-pay programs, and the cost ranges from a $25 copay to about $699 a month. If you have Medicare Part D and your BMI qualifies, the Medicare GLP-1 Bridge covers Wegovy, Zepbound KwikPen and Foundayo for weight loss at $50 a month through December 31, 2027.

Ozempic, Wegovy, Mounjaro, Zepbound and the new pill Foundayo are GLP-1 medicines. Their list prices are over $1,000 a month, but few people pay that. What you pay depends on why the drug is prescribed (diabetes or weight), what coverage you have, and which form of the drug you use. This guide walks through each way to pay, as of October 2026.

Does commercial insurance cover GLP-1s?

Commercial insurance means a plan from your job or one you buy yourself. Most of these plans cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro). Coverage for weight loss (Wegovy, Zepbound, Foundayo) is much less common, because your employer chooses whether to include it.

In KFF's 2025 survey of employers, only 19% of firms with 200 or more workers covered GLP-1s for weight loss in their largest plan. Among the biggest firms (5,000 or more workers), it was 43% (KFF). Some employers that cover them add limits, such as a BMI cutoff or a required lifestyle program.

Even when a drug is covered, you may hit one of these hurdles:

  • Formulary: the list of drugs your plan covers. If a drug is not on it, the plan usually won't pay.
  • Prior authorization: your doctor has to send the plan paperwork showing you meet its rules (for example, a diagnosis or a BMI) before the plan will pay.
  • Step therapy: the plan wants you to try a cheaper option first, and only covers the drug if that didn't work.
  • Exclusion: the plan simply doesn't cover weight-loss drugs at all. A prior authorization can't fix this; only a different plan can.

If you have commercial coverage for the drug, the maker's savings card can lower your copay (see below).

Does Medicare cover Ozempic, Wegovy or Zepbound?

By law, regular Medicare drug plans (Part D) can't cover drugs used only for weight loss. But Part D can cover GLP-1s for other approved uses:

  • Type 2 diabetes: Ozempic and Mounjaro, through your Part D plan.
  • Heart risk: Wegovy, when prescribed to lower the risk of heart attack and stroke in people with heart disease.
  • Sleep apnea: Zepbound, for moderate to severe obstructive sleep apnea in adults with obesity.

For these uses, your plan's normal rules apply: its formulary, prior authorization and copays. Check your own plan's drug list.

For weight loss alone, there is a separate program: the Medicare GLP-1 Bridge. It started July 1, 2026 and runs through December 31, 2027. If you have Part D and meet its BMI rules, you pay $50 a month for any form of Wegovy, the Zepbound KwikPen, or Foundayo (CMS). People with type 2 diabetes, moderate to severe sleep apnea or fatty liver disease aren't eligible for the Bridge; their Part D plan handles it instead (Medicare.gov). Read our full guide: The Medicare GLP-1 Bridge, explained.

Medicare Open Enrollment runs October 15 to December 7, and changes start January 1 (Medicare.gov). If you don't have Part D, this is usually when you can add it.

Does Medicaid cover GLP-1s for weight loss?

It depends on your state. Medicaid must cover GLP-1s for approved uses like type 2 diabetes, but covering them for obesity is each state's choice. Only 13 states covered them for obesity as of January 2026, down from 16 in 2025 (KFF).

A new federal program, the BALANCE model, lets state Medicaid programs cover GLP-1s for weight loss at a price CMS worked out with the makers. States could start between May 2026 and January 1, 2027 (CMS). CMS has not posted a list of states that joined, so ask your state Medicaid office or your Medicaid health plan whether yours is in.

Do savings cards work for Wegovy, Zepbound and Ozempic?

Novo Nordisk (Ozempic, Wegovy) and Eli Lilly (Mounjaro, Zepbound, Foundayo) offer savings cards. They are for people with commercial insurance. Examples as of October 2026:

  • Wegovy: with insurance that covers it, you may pay as little as $25 a month, with a monthly savings limit (NovoCare).
  • Zepbound single-dose pen and Foundayo: with insurance that covers them, you may pay as low as $25 a month (Zepbound, Foundayo).

These cards can't be used with Medicare, Medicaid or other government coverage. The makers' terms say "governmental beneficiaries excluded." They also have yearly limits and can end at any time.

How much do GLP-1s cost without insurance?

Both makers now sell directly to people paying cash. Prices below are as of October 2026 and come from the official pages. They change often, so check the link before you order.

Self-pay prices per month, as of October 2026
DrugPriceWhere
Wegovy pen$199 for the first two fills of the two lowest doses (new patients, through Dec 31, 2026), then $349; $399 for Wegovy HD 7.2 mgNovoCare Pharmacy or a pharmacy coupon via TrumpRx
Wegovy pill$149 to $299, depending on doseNovoCare
Ozempic pen$199 for the first two fills (new patients, lowest doses), then $349; $499 for the 2 mg dosePharmacy coupon via TrumpRx
Zepbound KwikPen or vial$299 to $449, if you refill within 45 days; higher doses rise to $499 to $699 if you don'tLillyDirect
Foundayo pill$149 to $299, depending on dose; some lower prices last through Dec 31, 2026LillyDirect

TrumpRx.gov is a government site that lists these cash offers in one place. You don't buy from it. For Wegovy and Ozempic it gives you a coupon to show at a retail pharmacy; for Zepbound it sends you to LillyDirect. The offers are for self-pay only: if you have insurance or Medicare, what you pay won't count toward your deductible or out-of-pocket limit (TrumpRx, Medicare.gov). TrumpRx's own advice is worth following: check your copay first, since it may be lower.

Can I use my HSA or FSA for a GLP-1?

Often, yes. A health savings account (HSA) or flexible spending account (FSA) can pay for prescribed drugs that treat a medical condition. The IRS counts weight-loss costs when they treat a disease a doctor diagnosed, such as obesity, but not when the goal is appearance or general health (IRS Publication 502). Lilly lists Zepbound and Foundayo bought through LillyDirect as HSA/FSA eligible, but says eligibility may vary by plan (LillyDirect). Ask your plan administrator before you pay, and keep your receipts and prescription.

What about compounded semaglutide or tirzepatide?

Compounded drugs are made by a pharmacy that mixes the ingredients itself, rather than by the maker. They are often sold online at lower prices. Here is what the FDA says (FDA):

  • Compounded GLP-1s are not FDA-approved. The FDA does not check them for safety, effectiveness or quality before they are sold.
  • The FDA has received reports of people hurt by dosing mistakes, some needing a hospital stay. As of May 31, 2026 it had 990 reports for compounded semaglutide and more than 730 for compounded tirzepatide.
  • Some products use salt forms (semaglutide sodium or acetate) that differ from the approved drugs.
  • The FDA warns about fake Ozempic and illegal online sellers, and says not to buy products labeled "for research" or "not for human consumption."

If you are thinking about a compounded drug, talk it over with your doctor or pharmacist first.

Which way to pay fits you?

Ways to pay for a GLP-1, as of October 2026
RouteWho it's forTypical costWhat to do next
Commercial insurancePeople with a job-based or individual planYour plan's copay; often as little as $25 with a savings cardCheck your plan's formulary and ask about prior authorization
Medicare Part DMedicare members with type 2 diabetes, heart disease or sleep apneaYour plan's copay; varies by plan and phaseLook up the drug on your plan's formulary at Medicare.gov
Medicare GLP-1 BridgePart D members using it for weight loss who meet BMI rules$50 a monthAsk your doctor; see Medicare.gov/glp1bridge
MedicaidMedicaid members; weight-loss coverage depends on your stateSmall or no copay where coveredAsk your state Medicaid office if it covers obesity or joined BALANCE
Maker self-payPeople without coverage for the drug$149 to $699 a month, by drug and doseCompare NovoCare, LillyDirect and TrumpRx
HSA or FSAPeople with one of these accountsPays with pre-tax moneyAsk your plan administrator if it qualifies

What should I ask my insurer or pharmacy?

  1. Is this drug on my plan's formulary, and for which uses (diabetes, weight, heart, sleep apnea)?
  2. Does my plan exclude weight-loss drugs entirely?
  3. Do I need prior authorization or step therapy? What does my doctor need to send?
  4. What will I pay each month, and does that change during the year?
  5. Can I use the maker's savings card with my plan?
  6. If I have Medicare, am I eligible for the GLP-1 Bridge, or should this go through my Part D plan?
  7. Is a cash price lower than my copay for this fill?

How Check In helps once you have your medicine

Check In is a free AI companion for GLP-1s that you text. For this part of life on a GLP-1, it does three things:

  • Text “took my shot”

    It's logged, so your shot history is in one place.

  • It checks in two days after your shot

    A quick text to see how you're feeling, timed to your shot day.

  • Ask anything about your medicine

    Plain answers from the FDA label, with a picture when it helps.

Questions people ask

Does Medicare cover Ozempic for weight loss?

No. Ozempic is approved for type 2 diabetes, and Medicare Part D covers it for that. For weight loss, the Medicare GLP-1 Bridge covers Wegovy, Zepbound KwikPen and Foundayo instead, at $50 a month through December 31, 2027, for people who meet its BMI rules.

Can I use a Wegovy savings card with Medicare?

No. The makers' savings cards exclude Medicare, Medicaid and other government coverage. Coupons and discount programs also can't be applied to Medicare GLP-1 Bridge claims.

How much is Wegovy without insurance?

As of October 2026, NovoCare lists the Wegovy pen at $349 a month for most doses ($199 for a new patient's first two fills of the lowest doses through December 31, 2026) and $399 for Wegovy HD. The Wegovy pill is $149 to $299 a month depending on dose. Check NovoCare for current prices.

How much is Zepbound without insurance?

As of October 2026, LillyDirect lists the Zepbound KwikPen and vials at $299 to $449 a month, depending on dose, if you refill within 45 days. Higher doses cost $499 to $699 if you don't. Check LillyDirect for current prices.

Can I buy GLP-1s on TrumpRx?

Not directly. TrumpRx.gov lists the makers' cash prices and gives you a pharmacy coupon (Wegovy, Ozempic) or sends you to the maker (Zepbound through LillyDirect). It's for self-pay only, and what you pay won't count toward an insurance deductible.

Can I pay for Wegovy or Zepbound with my HSA?

Often, yes, when the drug is prescribed to treat a diagnosed condition such as obesity. Rules vary by plan, so ask your HSA or FSA administrator before you pay.

Sources

  1. CMS: Medicare GLP-1 Bridge
  2. CMS: Medicare GLP-1 Bridge, information for providers
  3. CMS: Medicare GLP-1 Bridge, information for pharmacies
  4. CMS: BALANCE Model
  5. Medicare.gov: Medicare GLP-1 Bridge
  6. Medicare.gov: Weight loss drugs
  7. Medicare.gov: Open Enrollment
  8. KFF: What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge
  9. Peterson-KFF Health System Tracker: Perspectives from employers on covering GLP-1 agonists for weight loss
  10. NovoCare: Price your Wegovy
  11. LillyDirect: Zepbound
  12. LillyDirect: Foundayo
  13. TrumpRx.gov
  14. TrumpRx.gov: Wegovy
  15. TrumpRx.gov: Ozempic
  16. TrumpRx.gov: Zepbound
  17. Ozempic.com (indication)
  18. IRS Publication 502: Medical and Dental Expenses
  19. FDA: Concerns with unapproved GLP-1 drugs used for weight loss

Published October 26, 2026. General information, not medical, legal or insurance advice. Check with your prescriber, pharmacist or plan.

Keep reading